Wireless’ deep brain stimulation technique offers promising potential for neurodegenerative diseases BEIJING — Parkinson’s ...

With support from the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Health (OASH), the National Institutes of Health (NIH) is leading the implementation of ...

This free half-day event will feature three panels of subject matter experts discussing the latest advancements in ...

Parkinson's disease (PD) is the second most common neurodegenerative disorder, primarily characterized by motor dysfunction.

This insightful interactive webinar delves into the motor and non-motor symptoms experienced by patients with Parkinson’s ...

Ketamine disrupts abnormal brain activity, offering long-term relief for Parkinson’s dyskinesia in early clinical trials.

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...